WeTrials shared a post on X:
“What is Neuroblastoma?
It’s one of the most common solid tumors in children under six – and one of the toughest to treat.
In this short clip, Dr. Giselle Sholler, Chair of the Beat Childhood Cancer Research Consortium, explains how neuroblastoma forms, why it can spread so quickly, and how newer therapies like DFMO are changing the story for many families.
Every breakthrough begins with a clinical trial – and understanding is the first step toward hope.
Watch the full conversation with Dr. Sholler and Janet Fanaki on the WeTrials Podcast to learn more about:
- What clinical trials mean for kids with rare cancers
- How families and researchers are working together to find answers
- Why collaboration is speeding up access to better treatments
Stay tuned for Part 2, where we dive deeper into how pediatric trials are designed, why collaboration matters, and how the Beat Childhood Cancer network is bringing hope worldwide.
Watch the full episode.
Explore simplified clinical trials.”
Proceed to the video attached to the post.
You Can Also Read:
ASCO24 Updates: Lucas Moreno on Therapies for High-Risk Neuroblastoma
